Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 27, 2024Molecular Biology ReportsOpen Access

Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity

View Full Paper
Ask AI
Bookmark
Share

Authors

HDHevna DhulkifleLTLubna TherachiyilMHMaram Hasan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dhulkifle et al. (2024) studied this question.

synapsesocial.com/papers/68e5ec4fb6db64358758187dhttps://doi.org/10.1007/s11033-024-09803-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Doxorubicin induced heart failure: Phenotype and molecular mechanisms2015 · 319 citations
  2. 2Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase2014 · 138 citations
  3. 3Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice2020 · 96 citations
  4. 4Heart function and hemodynamic analysis for zebrafish embryos2017 · 187 citations
  5. 5Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model2017 · 52 citations